3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
13
Active not recruiting
5
Recruiting
4
Terminated
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
63
Lymphoid
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Conditions
Squamous Cell Carcinoma of Head and Neck
98
Head and Neck Neoplasms
91
Nasopharyngeal Carcinoma
53
Thyroid Neoplasms
30
Mouth Neoplasms
24
Thyroid Cancer, Papillary
15
Carcinoma, Squamous Cell
14
Carcinoma, Non-Small-Cell Lung
14
Oropharyngeal Neoplasms
13
Neoplasm Metastasis
13
Laryngeal Neoplasms
12
Neoplasms
11
Uterine Cervical Neoplasms
10
Colorectal Neoplasms
10
Breast Neoplasms
10
Thyroid Nodule
8
Thyroid Diseases
7
Nasopharyngeal Neoplasms
7
Melanoma
7
Lung Neoplasms
7
Hypopharyngeal Neoplasms
7
Ovarian Neoplasms
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Recurrence
5
Esophageal Neoplasms
5
Endometrial Neoplasms
5
Carcinoma, Renal Cell
5
Thyroid Carcinoma, Anaplastic
4
Stomach Neoplasms
4
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Glioma
×
Head & Neck
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled